Clinical Trials in Illinois

Showing 4201-4220 of 14,599 trials

Testing a Family Service Navigator Program for Low-resourced Families of Young Children with Autism Spectrum Disorder

NCT05099705

The purpose of this study is to develop and test a family navigator training and an app (a technology-based treatment support system) for low-resourced families of young children (aged 3-5) with autism. The hypothesis is that the navigator training and treatment support system will help enable navigators to support families of young children with autism in accessing needed services.

Autism Spectrum DisorderMental Health Services

Vanderbilt University55 participantsStarted Jul 2022

Champaign, Illinois, United States

COMPLETEDPhase 1/2125 miles

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

NCT02140554

This is a non-randomized, open label, multi-site, single dose, Phase 1/2 study in approximately 50 adults and adolescents with severe SCD. The study will evaluate hematopoietic stem cell and progenitor stem cell (collectively referred to as hematopoietic stem and progenitor cells or HSPCs) transplantation using lovo-cel.

Sickle Cell Disease

Genetix Biotherapeutics Inc.54 participantsStarted Feb 2015

Birmingham, Alabama, United States • Oakland, California, United States • Atlanta, Georgia, United States +8 more locations

COMPLETEDPhase 2125 miles

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

NCT02222155

The aim of this trial is to test the safety and efficacy of two dose regimens of the complement C5a receptor CCX168 in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Funding Source - FDA OOPD

ANCA-associated Vasculitis

Amgen42 participantsStarted Feb 2015

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +40 more locations

Testing a Family Service Navigator Program for Low-resourced Families of Young Children with Autism Spectrum Disorder

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

Find Trials by Condition in Illinois

Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Brain Injury Rehabilitation Improving the Transition Experience

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function

Angio-IMR and Cardiac MR-derived MVO in STEMI Patients

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

SNV1521 in Participants with Advanced Solid Tumors

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer

Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Intervention to Enhance PrEP Persistence

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay